Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice
Open Access
- 1 June 2007
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 129 (5), 957-968
- https://doi.org/10.1016/j.cell.2007.03.051
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- The p110α isoform of PI3K is essential for proper growth factor signaling and oncogenic transformationProceedings of the National Academy of Sciences of the United States of America, 2006
- Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesisNature Reviews Cancer, 2006
- Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?Trends in Cell Biology, 2004
- The RAF proteins take centre stageNature Reviews Molecular Cell Biology, 2004
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Activation of Phosphoinositide 3-Kinase γ by RasCurrent Biology, 2002
- Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumoursNature, 2002
- Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiationOncogene, 2002
- Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasiaThorax, 2001
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994